Work

CYT01B, a Novel RAD51 Inhibitor, Act Synergistically with Both Targeted and Chemotherapeutic Anti-Cancer Agents

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-119373

Authors: Tyler Maclay, Joseph Vacca, Casey McComas, Alfredo Castro, Melinda Day, Kevin Mills

Institution: Cyteir Therapeutics (United States)

Language: English

Topic: DNA Repair Mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2915287167

Cites:

Cited by: 5

Related to: 10